New Dual-Drug pump system shows promise for taming blood sugar spikes
NCT ID NCT06422325
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new closed-loop system that automatically delivers both insulin and pramlintide to manage blood sugar in 33 adults with type 1 diabetes. Pramlintide slows digestion to prevent blood sugar spikes after meals. The system was compared to insulin alone. Researchers measured how well it controlled blood sugar after meals. This is an early step toward a more automated diabetes management system.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pramlintide
- What this could lead to
- If successful, this approach could lead to better blood sugar control after meals for people with type 1 diabetes, reducing dangerous spikes.
- What could go wrong
- This is a small, early-stage study with only 33 participants. The system is complex and may not work for everyone. Pramlintide can cause nausea or low blood sugar.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Three telehealth sessions could ease the burden of type 1 diabetes on families
- Menstrual cycle timing may change how exercise impacts blood sugar in type 1 diabetes
- Can screening for social needs improve diabetes care for kids?
- A simple nudge after childbirth could transform lifelong health for moms with chronic conditions
- Can a four-week program boost diabetes tech use in teens?
- Scientists target GLUT1 to tame immune attacks in type 1 diabetes